These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31825142)

  • 1. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
    Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
    Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
    Pahle J; Menzel L; Niesler N; Kobelt D; Aumann J; Rivera M; Walther W
    BMC Cancer; 2017 Feb; 17(1):129. PubMed ID: 28193196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-Targeted Suicide Gene Therapy for Claudin-Overexpressing Tumor Cells by Using Modified Clostridium perfringens Enterotoxin (CPE).
    Beier LS; Piontek J; Piontek A; Protze J; Kobelt D; Walther W
    Methods Mol Biol; 2022; 2521():173-188. PubMed ID: 35732998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
    Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
    Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directed structural modification of Clostridium perfringens enterotoxin to enhance binding to claudin-5.
    Protze J; Eichner M; Piontek A; Dinter S; Rossa J; Blecharz KG; Vajkoczy P; Piontek J; Krause G
    Cell Mol Life Sci; 2015 Apr; 72(7):1417-32. PubMed ID: 25342221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A claudin 3 and claudin 4-targeted Clostridium perfringens protoxin is selectively cytotoxic to PSA-producing prostate cancer cells.
    Romanov V; Whyard TC; Waltzer WC; Gabig TG
    Cancer Lett; 2014 Sep; 351(2):260-4. PubMed ID: 24952257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.
    English DP; Santin AD
    Int J Mol Sci; 2013 May; 14(5):10412-37. PubMed ID: 23685873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer.
    Gabig TG; Waltzer WC; Whyard T; Romanov V
    Biochem Biophys Res Commun; 2016 Sep; 478(2):887-92. PubMed ID: 27520378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
    Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
    Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.
    Li X; Saeki R; Watari A; Yagi K; Kondoh M
    Eur J Pharm Sci; 2014 Feb; 52():132-7. PubMed ID: 24231339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for
    Vecchio AJ; Rathnayake SS; Stroud RM
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Modified
    Beier LS; Rossa J; Woodhouse S; Bergmann S; Kramer HB; Protze J; Eichner M; Piontek A; Vidal-Y-Sy S; Brandner JM; Krause G; Zitzmann N; Piontek J
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.
    Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J
    Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors.
    Walther W; Petkov S; Kuvardina ON; Aumann J; Kobelt D; Fichtner I; Lemm M; Piontek J; Blasig IE; Stein U; Schlag PM
    Gene Ther; 2012 May; 19(5):494-503. PubMed ID: 21975465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polar and charged extracellular residues conserved among barrier-forming claudins contribute to tight junction strand formation.
    Piontek A; Rossa J; Protze J; Wolburg H; Hempel C; Günzel D; Krause G; Piontek J
    Ann N Y Acad Sci; 2017 Jun; 1397(1):143-156. PubMed ID: 28415153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
    Casagrande F; Cocco E; Bellone S; Richter CE; Bellone M; Todeschini P; Siegel E; Varughese J; Arin-Silasi D; Azodi M; Rutherford TJ; Pecorelli S; Schwartz PE; Santin AD
    Cancer; 2011 Dec; 117(24):5519-28. PubMed ID: 21692061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
    Uthayanan L; El-Bahrawy M
    J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin.
    Robertson SL; Smedley JG; McClane BA
    Infect Immun; 2010 Jan; 78(1):505-17. PubMed ID: 19884339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin.
    Shrestha A; McClane BA
    mBio; 2013 Jan; 4(1):. PubMed ID: 23322640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the interaction of Clostridium perfringens enterotoxin with claudins.
    Veshnyakova A; Protze J; Rossa J; Blasig IE; Krause G; Piontek J
    Toxins (Basel); 2010 Jun; 2(6):1336-56. PubMed ID: 22069641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.